Comparison of prognostic values of cardiopulmonary and heart rate parameters in exercise testing in men with heart failure by Czubaszewski, Łukasz et al.
Address for correspondence: Łukasz Czubaszewski, MSc, PhD, Department of Physical Therapy and Rehabilitation,  
University of Physical Education, ul. Droga Dębińska 10c, 61–555 Poznań, Poland, e-mail: czubaszewski.awf@gmail.com
Received: 14.09.2016 Accepted: 13.04.2017
Comparison of prognostic values  
of cardiopulmonary and heart rate parameters  
in exercise testing in men with heart failure
Łukasz Czubaszewski1, Anna Straburzyńska-Lupa1,  
Jacek Migaj2, Ewa Straburzyńska-Migaj2
1University of Physical Education, Poznan, Poland 
21st Department of Cardiology University of Medical Sciences,  
University Hospital of Lord’s Transfiguration, Poznan, Poland
Abstract
Background: Cardiopulmonary exercise testing (CPET) is the gold standard in the evaluation of 
patients with chronic heart failure (CHF). However, this test is relatively expensive, assessment of its 
results requires experience, and in Poland it is available only in tertiary health care centers. Many heart 
rate (HR) parameters taken during a standard electrocardiographic (ECG) exercise test also shows 
prognostic values. Thus, the aim of this study is to compare prognostic values of ventilatory and HR 
parameters in exercise testing in CHF patients, and to find out if HR parameters can be used instead 
of ventilatory in the evaluation of a prognosis.
Methods: One hundred thirty two men (mean age 49 ± 11 years) with CHF with reduced left ventricu-
lar ejection fraction (< 45%) underwent a treadmill CPET using a modified Bruce’s protocol, during 
which both HR and ventilatory parameters were measured. The patients were followed for 27 ± 13  
months after CPET.
Results: Mortality was 28% (n = 37). Non-survivors demonstrated significantly shorter exercise time 
(342 ± 167 vs. 525 ± 342 s, p < 0.001), lower maximal HR (122 ± 22 vs. 138 ± 21 bpm, p < 0.001), 
smaller difference between maximal HR and at rest (36 ± 19 vs. 52 ± 21 bpm, p < 0.001), and lower 
HR recovery rate (HRR; 16 ± 10 vs. 24 ± 13 bpm, p = 0.002), chronotropic index (CHI; 0.45 ± 0.23 
vs. 0.61 ± 0.23, p < 0.001), peak oxygen consumption (13.82 ± 4.62 vs. 18.54 ± 5.68 mL/kg/min,  
p < 0.001) and oxygen uptake efficiency slope (OUES) value (1.56 ± 0.58 vs. 1.94 ± 0.63, p = 0.001), and  
higher ventilation to carbon dioxide production (VE/VCO2) slope value (40.56 ± 9.11 vs. 33.33 ± 7.36, 
p < 0.001). Two parameters that showed good prognostic value and availability in a routine CPET 
were chosen for receiver operating characteristic analysis, VE/VCO2 slope and CHI, which showed cut-
off values of 35 (sensitivity 74%, specificity 71%, p < 0.001) and 64 (sensitivity 74%, specificity 68%, 
p < 0.001) respectively.
Conclusions: Heart rate parameters show significant prognostic values; CHI is the best of them, 
however, it is weaker than VE/VCO2 slope. HR parameters show somewhat weaker prognostic values 
in comparison with ventilatory parameters, yet they may be useful in cases of CPET unavailability. 
(Cardiol J 2018; 25, 6: 701–708)
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Introduction
Chronic heart failure (CHF) is a growing health 
care issue due to the increasing number of patients, 
especially those at high-risk of hospitalization 
and death. It is necessary to evaluate prognosis 
of CHF patients in order to qualify them for ap-
propriate treatment. Cardiopulmonary exercise 
testing (CPET) is the gold standard recommended 
by the European Society of Cardiology and Ameri-
can Heart Association guidelines [1]. It measures 
ventilatory and heart rate (HR) parameters dur-
ing exercise; the most important in evaluation of 
CHF patients are peak VO2 and VE/VCO2 slope 
[2–5]. However, CPET is a time-consuming test, 
assessment of its results requires experience, and 
in Poland it is available only in tertiary health care 
centers. It might be possible to substitute CPET 
in primary health care with a routine electrocar-
diographic (ECG) exercise test, which has much 
greater availability, but measures only HR param-
eters. Their use in evaluation of CHF patients has 
not been studied thoroughly, but there is evidence 
that they also show some prognostic value [6–8]. 
The aim of the hereby-presented analysis is to 
compare prognostic values of ventilatory and HR 
parameters in exercise testing in CHF patients, and 
to find out if HR parameters can be used instead of 
ventilatory in evaluation of prognosis.
Methods
This retrospective single-center registry 
analyzed CPET results of 132 male patients with 
CHF, 42% (n = 58) of whom had ischemic car-
diomyopathy and the rest dilated cardiomyopathy. 
The CPET was performed in patients considered 
for heart transplantation. Only male patients 
were included to eliminate influence of gender 
on the results. All patients included participated 
between 1 January 2006 and 31 December 2008, 
and inclusion criteria consisted of availability of 
full medical documentation, stable CHF and left 
ventricular ejection fraction (LVEF) lower than 
45%. If a patient underwent multiple CPETs, only 
the first of them was considered. All the patients 
underwent a maximal symptom-limited CPET on 
a treadmill using Bruce’s protocol modified for 
CHF (one stage added at the beginning: 3 min, 
1.7 km/h, 5% slope). All tests were terminated 
because of dyspnea or exhaustion. SensorMedics 
Vmax 29 device (Becton, Dickinson and Company, 
US) was used to examine gas exchange during the 
tests. Each patient underwent spirometry before 
the test. GE Medical Systems IT Case 4.13 was 
used to analyze ECG during CPET. HR at rest was 
evaluated as 1 min average HR of the last minute 
during few minutes standing before CPET. HR 
peak was defined as HR at peak exercise calculated 
with the system.
The following ventilatory parameters were 
assessed: peak VO2 (mean value from the last 
20–30 s of the test [9]), VE/VCO2 slope (calculated 
for VE/VCO2 graph for the whole test; y = mx + b, 
where b = slope [3]), oxygen uptake efficiency 
slope (OUES; VO2 = alogVE + b, where a = OUES 
[3]), respiratory exchange ratio (RER), and HR 
parameters: HR at rest (HR rest), peak HR, chro-
notropic reserve (DHR; peak HR – HR rest), 
chronotropic index (CHI) and HR recovery (HRR; 
peak HR – HR 1 min after exercise). CHI is shown 
as percentage of chronotropic reserve using the 
following formula: CHI = DHR / [(220 – age) – HR 
rest] × 100%. 
Statistical analysis
Statistical analysis was performed using STA-
TISTICA 9, Statsoft. Probability distribution of 
continuous variables was tested with Shapiro-Wilk 
test. Most continuous variables had non-normal 
distribution, and Mann-Whitney U test was used 
to analyze them. Chi-square tests were used for 
categorical variables. Univariate regression mod-
els, log rank tests and Kaplan-Maier plots were 
used to assess unadjusted survival. Receiver op-
erating characteristic (ROC) analysis was used to 
find reference values for chosen parameters (VE/ 
/VCO2 slope and CHI). The data is expressed as 
mean values with standard deviation for continuous 
variables and percentages for categorical variables. 
A p value of < 0.05 was considered statistically 
significant for all the tests.
Results
Patients were followed for 27 ± 13 months 
and 28% (n = 37) of them died during this time. 
Patients who died did not differ significantly as to 
anthropometric data. However, they demonstrated 
significantly lower LVEF, higher incidence of coro-
nary artery disease (CAD) and were more likely to 
be treated with diuretics (Table 1). There were 12 
(12.6%) patients with atrial fibrillation in the survi-
vors group vs. 6 (16.6%) in non-survivors, as well 
as 13 (13.7%) vs. 4 (10.8%) patients respectively 
with implantable cardioverter-defibrillator, in that 
1 patient with cardiac resynchronization therapy in 
each group. There were 12 patients with implanted 
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pacemakers (9.5% vs. 8.1%, respectively) with no 
pacemaker related chronotropic incompetence.  
The patients who died demonstrated signifi-
cantly worse CPET results, both ventilatory and 
chronotropic; all the patients performed a maximal 
test as shown by RER values above 1.0 (Table 2), 
which means that all parameters can be used in 
evaluation of prognosis [10, 11]. There was no sig-
nificant difference in RER values between groups 
which underscores that the effort during exercise 
was similar in both groups. Univariate regression 
models showed significant prognostic values of 
all the investigated CPET parameters (Table 3). 
anaerobic treshold and CHI showed the strongest 
prognostic values, however, VE/VCO2 slope and 
Table 1. General characteristics.
Alive Dead P
Age [years] 49 ± 11 50 ± 11 0.79
Height [cm] 176.8 ± 7.4 173.9 ± 5.9 0.05
Body weight [kg] 86.6 ± 14.9 82.4 ± 17.3 0.19
Body mass index [kg/m2] 27.6 ± 4.1 27.1 ± 4.9 0.44
Left ventricular ejection fraction [%] 29 ± 7 24 ± 7 < 0.001
Dilated cardiomyopathy 62% 40% 0.030
Arterial hypertension 32% 43% 0.30
Diabetes mellitus 13% 23% 0.19
ACEI/ARB 87% 80% 0.45
Diuretics 79% 97% 0.008
Acetylsalicylic acid 53% 66% 0.23
Statins 57% 63% 0.55
Beta-blockers 92% 86% 0.30
ACEI — angiotensin converting enzyme inhibitor, ARB — angiotensin receptor blocker
Table 2. Cardiopulmonary exercise test results.
Alive Dead P
Exercise duration [s] 525 ± 199 342 ± 167 < 0.001
Peak HR 138 ± 21 122 ± 22 < 0.001
DHR 52 ± 21 36 ± 19 < 0.001
CHI [%] 61 ± 23 45 ± 23 < 0.001
HRR 24 ± 13 16 ± 10 0.002
Peak VO2 [mL/kg/min] 18.5 ± 5.7 13.8 ± 4.6 < 0.001
OUES 1.9 ± 0.6 1.6 ± 0.6 0.001
VE/VCO2 slope 33.3 ± 7.4 40.6 ± 9.1 < 0.001
RER 1.06 ± 0.07 1.06 ± 0.08 0.99
HR — heart rate; DHR — peak HR – HR at rest; CHI — chronotropic index; HRR — heart rate recovery 1 min after exercise; VO2 — oxygen  
uptake; OUES — oxygen uptake efficiency slope; VE/VCO2 — ventilation to carbon dioxide production; RER — respiratory exchange ratio
Table 3. Univariate regression model.
Hazard  
ratio
Confidence 
interval
P
VE/VCO2 slope 1.08 1.04–1.12 < 0.001
Peak VO2 0.85 0.79–0.92 < 0.001
OUES 0.59 0.37–0.93 0.025
AT 0.27 0.14–0.54 < 0.001
DHR 0.97 0.95–0.98 < 0.001
CHI 0.24 0.19–0.29 < 0.001
Peak HR 0.97 0.96–0.99 < 0.001
HRR 0.95 0.92–0.98 < 0.001
AT — anareobic treshold; HR — heart rate; DHR — peak HR – HR at 
rest; CHI — chronotropic index; HRR — heart rate recovery 1 min 
after exercise; VO2 — oxygen uptake; OUES — oxygen uptake  
efficiency slope; VE/VCO2 — ventilation to carbon dioxide production
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CHI were chosen for further analyses. The reason 
for this choice was that these two parameters do 
not depend on intensity of exercise as much as the 
others do. Many patients are not able to perform 
a maximal exercise and they do not reach peak HR 
or peak VO2; it is also estimated that in ca. 30% pa-
tients it was not possible to find anaerobic treshold. 
ROC analysis of VE/VCO2 slope and CHI 
showed the best cut-off values of 35 (specific-
ity 71% and sensitivity 74%, p < 0.001) (Fig. 1) 
and 64 (specificity 68% and sensitivity 74%, 
p < 0.001) (Fig. 2), respectively. VE/VCO2 slope 
had a greater area under curve (0.73 vs. 0.71). 
Survival probability analysis showed 83% 12-month 
survival probability for patients with CHI ≤ 64% 
and 98% for those with CHI > 64% (p < 0.001) 
(Fig. 3). Similarly, 12-month survival probability 
for patients with VE/VCO2 slope ≥ 35 was 81% 
and for those with VE/VCO2 slope < 35 was 93% 
(p < 0.001) (Fig. 4).
Discussion
The main findings of this study are: 1) HR 
parameters show significant prognostic values 
in patients with CHF; 2) CHI is the strongest 
prognostic marker among HR parameters; 3) HR 
parameters show somewhat weaker prognostic 
values in comparison with ventilatory parameters; 
4)CHI provides a useful cut-off point (64%) simi-
larly to VE/VCO2 slope (35).
High quality diagnostics are necessary to 
qualify patients for heart transplantation and 
implantation of left ventricular assistant devices. 
The following parameters are most often used 
in evaluation of CHF patients: LVEF, New York 
Heart Association classification, peak VO2, he-
matocrit, QRS width, tachycardia at rest and lack 
of reaction to standard treatment [12, 13]. CPET 
is a gold-standard test used in evaluation of CHF 
patients, particularly those considered for heart 
transplantation [3, 14]. In spite of growing number 
of studies confirming value of CPET in clinical 
evaluation of various groups of patients, with peak 
VO2 as the ‘gold standard’ in evaluation of physical 
fitness, this examination is still rarely performed. 
It is a relatively expensive test and interpretation 
of its results requires experience [1]. As it is not 
easily accessible, there is a need for other param-
eters with prognostic values similar to those of 
ventilatory parameters, but easier to obtain in e.g. 
outpatient care [15–17]. A standard ECG exercise 
test is easily accessible and inexpensive. It is com-
monly used for clinical evaluation of e.g. patients 
with CAD and its interpretation is easier. However, 
physical fitness is only estimated during such 
a test, as it cannot be measured directly without 
considering ventilatory parameters. 
Peak VO2, estimated as mean VO2 in the last 
20 s or 30 s of a test was considered the best 
prognostic marker for a long time [9]. However, 
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Figure 1. Receiver operating characteristic analysis 
of ventilation to carbon dioxide production (VE/VCO2) 
slope; AUC — area under curve.
Figure 2. Receiver operating characteristic analysis of 
chronotropic index; AUC — area under curve.
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many authors showed that this value depends on 
the intensity of exercise, and it has the greatest 
prognostic value when RER is higher than 1.0 
[10, 11]. In the present study, all the patients per-
formed maximal exercise as shown by mean RER 
1.06, and there was no difference between the 
survivors and the non-survivors. Therefore, the 
obtained peak VO2 values could be used in analyses. 
Recent years have witnessed a growing importance 
of VE/VCO2 slope; its small dependence on the 
intensity of performed exercise made it the most 
important CPET parameter in evaluation of prog-
nosis in CHF patients [18]. VE/VCO2 slope above 
34 or 36 is considered the best risk marker [2, 13]. 
Many authors confirm that VE/VCO2 slope has 
a better prognostic value than peak VO2 [19, 20]. 
Figure 4. Survival probability curves for patients with ventilation to carbon dioxide production (VE/VCO2) slope ≥ 35.
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Figure 3. Survival probability curves for patients with chronotropic index (CHI) ≤ 64%.
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This study confirmed the findings of the cited 
authors in showing that the best cut-off point for 
VE/VCO2 slope is 35. 
Several studies show that a multiple-marker 
approach to evaluation of CHF patients may have 
advantages over the traditional approach. These 
include models such as VE/VCO2 slope, HRR, 
OUES, PetCO2 and peak VO2 [2]. Each of these may 
be used as a prognostic marker independently, but 
combined they show a greater prognostic value [2]. 
This model does not include CHI because numer-
ous studies show that the only significant HR 
parameter independent from beta-blocker use is 
HRR [19, 20]. In this study, univariate regression 
models showed significant prognostic values of all 
the investigated parameters, not only ventilatory, 
but also HR parameters, including CHI, HRR, 
HRmax and DHR. These parameters can also be 
obtained in a standard ECG exercise test without 
analysis of gas exchange, and their value in evalu-
ation of patients with CAD was confirmed by nu-
merous authors [21]. There are very few studies 
investigating usefulness of CHI in CHF patients, 
and their results are inconsistent [7, 8, 16].
Usefulness of HR parameters remains con-
troversial because of wide use of beta-blockers in 
CHF patients. Peak HR depends strongly on use 
of beta-blockers. That is why CHI was developed 
based on estimated HR reserve [22]. Initially, 
a cut-off point of 80% was proposed for CHI [6], 
which however was not confirmed in other studies 
[7, 12]. Other authors showed a significant cut-off 
point of 62% for CHI in patients with known or 
suspected CAD treated with beta-blockers [23] 
or 65% in patients with CHF [24]. A subanalysis 
of HF-ACTION trial in patients with CHF with 
reduced LVEF treated with beta-blockers showed 
that CHI had no significant prognostic value in 
a multivariate analysis. However, this study showed 
that CHI below 60% indicated worse prognosis, i.e. 
all-cause and cardiac mortality or hospitalizations 
due to CHF [25]. Al-Najjar et al. [26] have found 
that patients with CHI had lower exercise time 
and peak VO2, however CHI was not a significant 
predictor of mortality. 
Chronotropic index is a measure of chrono-
tropic incompetence which is defined as an impair-
ment of normal increase of HR with incremental 
exercise. In heart failure sympathetic over activity 
leads to beta-receptor downregulation and reduced 
myocardial sensitivity to beta-agonists, which may 
further lead to impaired HR response to exercise. 
Chronotropic incompetence is related to exercise 
intolerance, and increases with severity of HF 
regardless of presence of beta-blocker therapy or 
beta-blocker daily dose [7]. The controversy ex-
ists if CHI contribute to exercise intolerance or 
merely reflect work performed or the duration of 
exercise rather than being a discrete pathological 
entity [8, 26]. 
The present analysis showed that both the 
gold-standard ventilatory parameters and the HF 
parameters of CPET have significant prognostic 
values in men with CHF. Ventilatory parameters 
are the best prognostic markers, particularly oxy-
gen uptake at peak exercise (peak VO2) and the 
marker of increased exertional ventilation (VE/ 
/VCO2 slope) as shown in numerous other studies 
[15, 27–30]. HR parameters demonstrated some-
what weaker prognostic value; CHI, peak HR and 
HRR are the most important. The strongest HR 
parameter is CHI, which is however, weaker than 
VE/VCO2 slope as shown in ROC analysis. Both 
VE/VCO2 slope and CHI provide cut-off points 
that clearly distinguish patients with good and 
poor prognosis. In this study, patients with CHI 
above 64% demonstrated higher long-term survival 
probability than those with CHI below 64%. Most 
of these patients (90%) were treated with beta-
blockers, and results are consistent with previously 
cited works. Similar to the present findings Goda 
et al. [31] reported, using HR increase (HR dif-
ference from rest to peak exercise) and HRR (HR 
difference from peak to 2 min after exercise) as HR 
parameters and CEPT parameters, that although 
HR profiles during exercise are easy to perform 
and useful prognostic markers in patients with 
cardiovascular disease (ischemic heart disease, 
valvular heart disease, cardiomyopathies), they 
are not superior to respiratory gas analysis [31].
Limitations of the study
This is a single-center retrospective registry 
including only males with CHF, therefore it does 
not reflect the whole population of CHF patients. 
The results need to be confirmed in larger, multi-
center studies. A small group of the presented 
patients had atrial fibrillation, as in other previ-
ous studies [7, 26, 31], so generalizing results to 
patients with atrial fibrillation must be done with 
caution. This group of patients needs further study.
Conclusions
1. Heart rate parameters show significant prog-
nostic values in patients with CHF.
2. Chronotropic index is the strongest prognostic 
marker among HR parameters.
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3. Heart rate parameters show somewhat weaker 
prognostic values in comparison with ventila-
tory parameters, yet they may be useful in 
cases of CPET unavailability.
4. Chronotropic index provides a useful cut-off 
point (64%) similarly to VE/VCO2 slope (35).
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